Factor Bioscience
Cambridge, United States · Biotechnology, Health Care
Factor Bioscience was founded to pioneer new methods for controlling gene expression and cell fate. The company innovates across mRNA, gene editing, cell reprogramming, and nucleic acid delivery. With more than 150 granted patents, Factor Bioscience has helped unlock the potential of mRNA to treat disease and improve lives. Factor supports a model of unlimited discovery, believing that breakthr
Key facts
- Headquarters
- Cambridge, United States
- Employees
- 13
- Industries
- Biotechnology, Health Care
- Website
- factor.bio
- Company page
Recent activity at Factor Bioscience
Factor Bioscience funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Seed | $1.0M |
Leadership
- Christopher Rohde, Founder
- Matt Angel, Founder
- Kyle Garland, Vice President of Research and Development
Verified email and direct lines for Factor Bioscience’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Factor Bioscience files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Factor Bioscience in the news
- Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies - Life Biosciences (Jun 09, 2026)
- Lineage Takes Delivery of Genetically Engineered iPSC Line with Hypoimmunity Edits from Factor Bioscience - BioInformant (Jan 15, 2026)
- Von Willebrand factor A1 blockade prevents platelet-mediated sustained occlusion for the treatment of arterial thrombosis | Communications Biology - Nature (Jul 11, 2026)
- Talus Bioscience AI Platform Unlocks Transcription Factors - AllSci (Jul 09, 2026)
- Life Biosciences Raises $80M to Fund First Trial of Anti-Aging Gene Therapy - Inside Precision Medicine (Apr 09, 2026)
- Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib - PR Newswire (Sep 09, 2026)
- FDA clears first human trial of epigenetic reprogramming therapy - Longevity.Technology (Jan 28, 2026)
- Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies - Life Biosciences (Jan 28, 2026)
Companies similar to Factor Bioscience
- NanoVibronix · Biotechnology, Health Care
- AQ BioTech · Biotechnology, Health Care
- Lavior Pharma · Biotechnology, Health Care
- Eloxx Pharmaceuticals · Biotechnology, Health Care
- Healthcare Holding Schweiz AG · Biotechnology, Health Care
About Factor Bioscience: questions and answers
What does Factor Bioscience do?
Factor Bioscience was founded to pioneer new methods for controlling gene expression and cell fate. The company innovates across mRNA, gene editing, cell reprogramming, and nucleic acid delivery. With more than 150 granted patents, Factor Bioscience has helped unlock the potential of mRNA to treat disease and improve lives. Factor supports a model of unlimited discovery, believing that breakthr
Where is Factor Bioscience headquartered?
Factor Bioscience is headquartered in Cambridge, United States.
How many employees does Factor Bioscience have?
Factor Bioscience has about 13 employees.
Has Factor Bioscience raised funding?
Yes. Fundz has recorded 1 funding event for Factor Bioscience. The most recent, Seed of $1.0M, was in Sep 2025.
Who leads Factor Bioscience?
Christopher Rohde is a Founder at Factor Bioscience.
What is the latest news on Factor Bioscience?
On Sep 25, 2025, Factor Bioscience
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy